Contact this trialFirst, we need to learn more about you.
AMPA Receptor Antagonist
Perampanel for Status Epilepticus
Recruiting3 awardsPhase 4
Detroit, Michigan
This trial aims to understand epilepsy treatment better and see if a new drug is safe and effective. 25 patients will be tested and monitored for 96 weeks.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.